XML 26 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
SARs
Stock options
Common Stock
Common Stock
SARs
Common Stock
Stock options
Additional Paid in Capital
Additional Paid in Capital
SARs
Additional Paid in Capital
Stock options
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Beginning balance, shares outstanding (in shares) at Dec. 31, 2021       648,794,041              
Beginning balance at Dec. 31, 2021 $ 524,298     $ 648     $ 302,866     $ 0 $ 220,784
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 244,072                   244,072
Conversion of cash-settled units to stock-settled appreciation rights 1,632           1,632        
Issuance of shares upon settlement of stock-settled stock appreciation rights (in (shares)         214,380            
Issuance of shares upon settlement of stock-settled stock appreciation rights   $ 638           $ 638      
Shares withheld on settlement of stock-settled stock appreciation rights (in shares)         (106,722)            
Shares withheld on settlement of stock-settled stock appreciation rights   $ (1,412)           (1,412)      
Share-based compensation expense 7,275           7,275        
Issuance of shares upon exercise of stock options (in shares)           1,189,681          
Issuance of shares upon exercise of stock options     $ 1,877     $ 1     $ 1,876    
Unrealized gain (loss) on derivatives (net of taxes) 2,577                 2,577  
Ending balance, shares outstanding (in shares) at Dec. 31, 2022       650,091,380              
Ending balance at Dec. 31, 2022 780,957     $ 649     312,875     2,577 464,856
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 61,587                   61,587
Issuance of shares upon settlement of stock-settled stock appreciation rights (in (shares)   109,620     109,620            
Issuance of shares upon settlement of stock-settled stock appreciation rights   $ 326           326      
Shares withheld on settlement of stock-settled stock appreciation rights (in shares)   (83,501) (12,782,218) (12,782,218) (83,501)            
Shares withheld on settlement of stock-settled stock appreciation rights (24,095) $ (390)         (24,095) $ (390)      
Share-based compensation expense 9,072           9,072        
Issuance of shares upon exercise of stock options and vesting of restricted stock units (in shares)       23,396,654              
Issuance of shares upon exercise of stock options and vesting of restricted stock units 18,723     $ 22     18,701        
Issuance of shares upon exercise of stock options (in shares)     23,312,690                
Unrealized gain (loss) on derivatives (net of taxes) $ (1,212)                 (1,212)  
Ending balance, shares outstanding (in shares) at Dec. 31, 2023 660,731,935     660,731,935              
Ending balance at Dec. 31, 2023 $ 844,968     $ 671     316,489     1,365 526,443
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 19,522                   19,522
Share-based compensation expense 11,123           11,123        
Issuance of shares upon exercise of stock options and vesting of restricted stock units (in shares)       3,492,958              
Issuance of shares upon exercise of stock options and vesting of restricted stock units 919     $ (7)     926        
Issuance of shares upon exercise of stock options (in shares)     1,199,319                
Unrealized gain (loss) on derivatives (net of taxes) $ (2,130)                 (2,130)  
Ending balance, shares outstanding (in shares) at Dec. 31, 2024 664,224,893     664,224,893              
Ending balance at Dec. 31, 2024 $ 874,402     $ 664     $ 328,538     $ (765) $ 545,965